LADX
Price
$1.80
Change
+$0.19 (+11.80%)
Updated
Jul 7 closing price
Capitalization
891.17K
MREO
Price
$2.94
Change
+$0.11 (+3.89%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
467.46M
90 days until earnings call
Interact to see
Advertisement

LADX vs MREO

Header iconLADX vs MREO Comparison
Open Charts LADX vs MREOBanner chart's image
LadRx
Price$1.80
Change+$0.19 (+11.80%)
Volume$250
Capitalization891.17K
Mereo BioPharma Group
Price$2.94
Change+$0.11 (+3.89%)
Volume$36.86K
Capitalization467.46M
LADX vs MREO Comparison Chart in %
Loading...
LADX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LADX vs. MREO commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LADX is a StrongBuy and MREO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (LADX: $1.80 vs. MREO: $2.83)
Brand notoriety: LADX and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LADX: 28% vs. MREO: 151%
Market capitalization -- LADX: $891.17K vs. MREO: $467.46M
LADX [@Biotechnology] is valued at $891.17K. MREO’s [@Biotechnology] market capitalization is $467.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LADX’s FA Score shows that 0 FA rating(s) are green whileMREO’s FA Score has 1 green FA rating(s).

  • LADX’s FA Score: 0 green, 5 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, both LADX and MREO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LADX’s TA Score shows that 5 TA indicator(s) are bullish while MREO’s TA Score has 5 bullish TA indicator(s).

  • LADX’s TA Score: 5 bullish, 4 bearish.
  • MREO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LADX is a better buy in the short-term than MREO.

Price Growth

LADX (@Biotechnology) experienced а +18.42% price change this week, while MREO (@Biotechnology) price change was +2.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.91%. For the same industry, the average monthly price growth was +17.27%, and the average quarterly price growth was +18.94%.

Reported Earning Dates

LADX is expected to report earnings on May 14, 2025.

MREO is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+12.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($467M) has a higher market cap than LADX($891K). LADX YTD gains are higher at: 7.143 vs. MREO (-19.143). LADX has higher annual earnings (EBITDA): -3.51M vs. MREO (-44.87M). MREO has more cash in the bank: 62.5M vs. LADX (207K). LADX has less debt than MREO: LADX (0) vs MREO (747K). LADX (0) and MREO (0) have equivalent revenues.
LADXMREOLADX / MREO
Capitalization891K467M0%
EBITDA-3.51M-44.87M8%
Gain YTD7.143-19.143-37%
P/E Ratio1.88N/A-
Revenue00-
Total Cash207K62.5M0%
Total Debt0747K-
FUNDAMENTALS RATINGS
LADX vs MREO: Fundamental Ratings
LADX
MREO
OUTLOOK RATING
1..100
2913
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
10089
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
5046
P/E GROWTH RATING
1..100
962
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LADX's Valuation (47) in the Pharmaceuticals Other industry is in the same range as MREO (75) in the null industry. This means that LADX’s stock grew similarly to MREO’s over the last 12 months.

MREO's Profit vs Risk Rating (89) in the null industry is in the same range as LADX (100) in the Pharmaceuticals Other industry. This means that MREO’s stock grew similarly to LADX’s over the last 12 months.

MREO's SMR Rating (98) in the null industry is in the same range as LADX (100) in the Pharmaceuticals Other industry. This means that MREO’s stock grew similarly to LADX’s over the last 12 months.

MREO's Price Growth Rating (46) in the null industry is in the same range as LADX (50) in the Pharmaceuticals Other industry. This means that MREO’s stock grew similarly to LADX’s over the last 12 months.

MREO's P/E Growth Rating (2) in the null industry is significantly better than the same rating for LADX (96) in the Pharmaceuticals Other industry. This means that MREO’s stock grew significantly faster than LADX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LADXMREO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LADX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSCDX18.13N/A
N/A
MassMutual Small Cap Opps R5
LSEIX15.98N/A
N/A
Persimmon Long/Short I
LVAVX14.13N/A
N/A
LSV Conservative Value Equity Investor
SUWZX35.92N/A
N/A
DWS Core Equity R6
JACFX19.40N/A
N/A
JHancock Mid Cap Growth NAV

LADX and

Correlation & Price change

A.I.dvisor tells us that LADX and TCRX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LADX and TCRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LADX
1D Price
Change %
LADX100%
N/A
TCRX - LADX
22%
Poorly correlated
+17.24%
MREO - LADX
22%
Poorly correlated
-1.39%
NXTC - LADX
21%
Poorly correlated
+3.29%
NICXF - LADX
20%
Poorly correlated
N/A
IFRX - LADX
20%
Poorly correlated
+6.82%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-1.39%
CRNX - MREO
50%
Loosely correlated
+1.07%
NRIX - MREO
49%
Loosely correlated
-1.21%
RARE - MREO
47%
Loosely correlated
-0.48%
TRDA - MREO
46%
Loosely correlated
+2.73%
RXRX - MREO
45%
Loosely correlated
+8.72%
More